American Chemical Society: How a Retracted Paper Affected the Course of Alzheimer's Research
August 28, 2024
August 28, 2024
WASHINGTON, Aug. 28 (TNSres) -- The American Chemical Society issued the following agency statement on Aug. 26, 2024:
* * *
In June 2024, a landmark Alzheimer's research paper was retracted due to fraud allegations. Did we waste billions of dollars and thousands of hours of scientists' time? Maybe not.
There are now two potentially helpful drugs on the market targeting the subject of the paper: amyloid beta.
This video breaks down the amyloid . . .
* * *
In June 2024, a landmark Alzheimer's research paper was retracted due to fraud allegations. Did we waste billions of dollars and thousands of hours of scientists' time? Maybe not.
There are now two potentially helpful drugs on the market targeting the subject of the paper: amyloid beta.
This video breaks down the amyloid . . .